Skip to main content

Table 2 Risks identified through systematic review with their frequency of reporting

From: Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods

Category

Risks

No.

Category

Risks

No.

Category

Risks

No.

Supply & suppliers issues

Supply and supplier issue

6

Supply & suppliers issues

Flexibility in product variety

1

Financial issues

Tax payable change

3

Partnership with supplier

3

Timely delivery

1

Currency rate

3

Raw material quality

2

Quality management system

1

Financial risks

3

Ordering cycle time

2

Organization & strategies issues

Customer services disruption

1

Tariff policies changes

1

Contract & agreements

2

Inventory management

4

Costs related to supply

1

Customization of supplier

2

Operation issues

3

Cash Flow

1

Certificate of good manufacturing practices (GMP)

2

R & D

2

Interest rate

1

Flexibility of supplier

2

Skill of workers

2

Market issues

Market

2

Fragmentation

1

Strategy

2

Consumers taste

2

Delivery reliability

1

Planning issues

2

Demand

2

Environmental assessment

1

Information flow

1

Political issues

Natural disasters & Terrorism

3

Technology level

1

Visibility on stock

1

Political issues

1

Information systems

1

Organization & process

2

Sanction

1

Good will

1

Mergers and acquisition

1

logistic issues

Counterfeit

4

Technology development

1

Time to market

1

Transportation

3

Flexibility in delivering

1

waste management

1

Regulation

Regulation

6

Flexible quantities

1

Production cost

1